Dr. Greg Bailey

Dr Bailey has spent 25 years as an entrepreneur, executive and financier. He is the executive chairman and co-founder of Juvenescence Ltd a company focused on drugs to modify aging. He is on the board of directors of Biohaven Pharmaceuticals focused on neurology, ADC and degraders, Serina Therapeutics a biotech company with a platform LNP technology and Portage Biotech Inc. an oncology company. He’s the cofounder and chairman of Chelsea Avondale an insurance company, and Culminant Reinsurance along with a position on the board of directors of Manx Financial a tier one bank in the UK and the Isle of Man. He is the former director and financier of Medivation, cofounder of Ascent Healthcare solutions and VirnetX an Internet security company. He is the owner of Northstar Sail GP racing team.

Dr Bailey has spent 25 years as an entrepreneur, executive and financier. He is the executive chairman and co-founder of Juvenescence Ltd a company focused on drugs to modify aging. He is on the board of directors of Biohaven Pharmaceuticals focused on neurology, ADC and degraders, Serina Therapeutics a biotech company with a platform LNP technology and Portage Biotech Inc. an oncology company. He’s the cofounder and chairman of Chelsea Avondale an insurance company, and Culminant Reinsurance along with a position on the board of directors of Manx Financial Group a tier one bank in the UK and the Isle of Man. He is the former director and financier of Medivation Inc. (MDVN: NASDAQ) and cofounder of Ascent Healthcare solutions, for VirnetX Inc. Internet security company. He is the owner of Northstar Sail GP racing team.